Table 3.
Critical appraisal results for included studies using the JBI Critical Appraisal Checklist for Economic Evaluations
| Source | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Well-defined question | Comprehensive description of alternatives | All important and relevant costs and outcomes for each alternative identified | Clinical effectiveness established | Costs and outcomes measured accurately | Costs and outcomes valued credibly | Costs and outcomes adjusted for differential timing | Incremental analysis of costs and consequences | Sensitivity analyses conducted | Study results include all issues of concern to users | Results are generalizable | |
| Arling 1987 [44] | Yes | Yes | Yes | No | Unclear | Yes | No | No | No | Yes | No |
| Bland 1992 [37] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
| Davis 1993 [41] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | No |
| Farsi 2004 [36] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
| Holmes 1996 [45] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | No |
| Smith 1992 [50] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
| Sulvetta 1986 [49] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | No | Unclear |
| Ullmann 1984 [46] | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
| Ullmann 1986 [48] | Yes | No | Yes | No | Yes | Yes | No | No | No | Yes | Unclear |
| Ullmann 1987 [47] | Yes | Yes | Yes | No | Unclear | Yes | No | No | No | Yes | Unclear |
| Calkins 2007 [38] | Yes | Yes | Yes | No | Yes | Unclear | No | No | No | No | Yes |
| Chenoweth 2014 [40] | Yes | Yes | No | No | Unclear | Yes | No | No | No | No | Unclear |
| Jenkens 2011 [39] | Yes | Yes | Yes | No | Yes | Yes | No | No | Yes | Yes | Yes |
| Maas 1998 [35]; Swanson 1993 [42]; Swanson 1994 [43] | Yes | Yes | Yes | No | Unclear | Unclear | No | No | No | No | Unclear |